science
Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.
Penn helped test an mRNA cancer vaccine that succeeded in its late-stage clinical trial. “This was kind of the wake-up call that RNA vaccines in cancer have an enormous future,” Drew Weissman said.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Why this robot burns the tips off cotton plants with a Laser
Interesting Engineering
Clark Atlanta Lands Nearly $10M Pentagon Grant to Grow AI Research
Hoodline
NASA Studies Ancient Scottish Rocks To Unlock Mars’ Lost Past
The Daily Galaxy
AI predicts pancreatic cancer years before diagnosis
Earth.com
Deployable Energy to test its nuclear battery at INL's DOME
Postregister